Literature DB >> 10735014

American Cancer Society guidelines for the early detection of cancer.

R A Smith1, C J Mettlin, K J Davis, H Eyre.   

Abstract

This issue of CA inaugurates a yearly report on American Cancer Society guidelines for early detection of cancer in asymptomatic individuals. The current recommendations, which reflect almost 20 years of updates, cover screening recommendations for breast, colorectal, prostate, and cervical cancers, as well as for other cancers, depending on patient age, history, environmental and/or occupational exposures, etc. A key concept for both the general public and health providers is the distinction between public health recommendations regarding screening and decisions about early detection tests that might be undertaken on an individual basis. Although it is likely that current screening protocols will be supplanted by newer technologies, such as genetic and molecular markers of risk and disease, greater utilization of the technologies at hand will improve efforts toward establishing an organized and systematic approach to early cancer detection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735014     DOI: 10.3322/canjclin.50.1.34

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  35 in total

1.  Screening for lung cancer: can it be cost-effective?

Authors:  O S Miettinen
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

Review 2.  Racial Disparity Among the Head and Neck Cancer Population.

Authors:  Pedram Daraei; Charles E Moore
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

3.  Priorities in future research in prostate cancer screening.

Authors:  Fritz H Schröder
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines.

Authors:  Paula M Lantz; Peter A Ubel
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

5.  Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness.

Authors:  D Arioli; M Pipino; E Boldrini; E Amateis; A Cristani; P Ventura; E Romagnoli; M C De Santis; M L Zeneroli
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

6.  Reported skin cancer screening of US adult workers.

Authors:  William G LeBlanc; Liat Vidal; Robert S Kirsner; David J Lee; Alberto J Caban-Martinez; Kathryn E McCollister; Kristopher L Arheart; Katherine Chung-Bridges; Sharon Christ; John Clark; John E Lewis; Evelyn P Davila; Panta Rouhani; Lora E Fleming
Journal:  J Am Acad Dermatol       Date:  2008-04-24       Impact factor: 11.527

7.  Knowledge and opinions regarding oral cancer among Maryland dental students.

Authors:  Shahdokht Boroumand; A Isabel Garcia; Robert H Selwitz; Harold S Goodman
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

8.  The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study.

Authors:  Helena P Burden; Chris R Davis; Sophie Tate; Raj Persad; Chris H Holmes; Kate Whittington
Journal:  BMC Urol       Date:  2008-11-20       Impact factor: 2.264

9.  Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.

Authors:  Qi Wang; Jing Shen; Zhen-fu Li; Jian-zheng Jie; Wen-yue Wang; Jin Wang; Zhong-tao Zhang; Zhi-xia Li; Li Yan; Jin Gu
Journal:  BMC Cancer       Date:  2009-08-19       Impact factor: 4.430

10.  Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.

Authors:  Harriet Richardson; Kristan J Aronson; Alison James; Elizabeth S McGregor; Heather Bryant
Journal:  Open Med       Date:  2007-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.